Li Auto Shares Plunge After Updated Li L9 SUV Launch
Li Auto shares fell as new L9 SUV failed to impress; analysts mixed, sales weak, global launch planned for 2026.
Already have an account? Sign in.
Li Auto shares fell as new L9 SUV failed to impress; analysts mixed, sales weak, global launch planned for 2026.
Investors sold CGNX on valuation and cash spend.
FDA clears TriSalus’ TriNav Advance, designed to push more treatment into liver tumors and less into healthy tissue via a SmartValve.
The company says real-time quantum error decoding can run in the background on commodity hardware instead of custom FPGA, GPU, or ASIC farms.